Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,650
datasets available to search
ShareScore release 0.9.0
Dataset results
3,650 results for “antibody”
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05652868. IPD Sharing: YES. Countries: 7. Publications: 1.
A Study of the Safety and Pharmacokinetics of an Anti-Inflammatory Therapeutic Antibody (MABp1) in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01427699. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response
ClinicalTrials.gov study NCT02240888. IPD Sharing: Not stated. Countries: 1. Publications: 4.
The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV
ClinicalTrials.gov study NCT00001105. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Antibody Production Following H1N1 Influenza Vaccination in Organ Transplant Patients
ClinicalTrials.gov study NCT01254955. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose
ClinicalTrials.gov study NCT01173302. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Anti-PD-1 Antibody Alone or in Combination With Decitabine/Chemotherapy in Relapsed or Refractory Malignancies
ClinicalTrials.gov study NCT02961101. IPD Sharing: Not stated. Countries: 1. Publications: 5.
First-in-human Study With the Antibody-drug Conjugate SYD985 to Evaluate Safety and Efficacy in Cancer Patients
ClinicalTrials.gov study NCT02277717. IPD Sharing: UNDECIDED. Countries: 4. Publications: 2.
Seroprevalence of IgG Antibodies to SARS-CoV-2 (COVID-19) in Primary Health Care Workers and Their Household Contacts
ClinicalTrials.gov study NCT04808986. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma
ClinicalTrials.gov study NCT00032045. IPD Sharing: Not stated. Countries: 1. Publications: 5.
A Window-of-opportunity Study of U3-1402, a HER3-targeting Antibody-drug Conjugate in Operable Breast Cancer According to ERBB3 Expression
ClinicalTrials.gov study NCT04610528. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
ClinicalTrials.gov study NCT01279291. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection
ClinicalTrials.gov study NCT04750720. IPD Sharing: Not stated. Countries: 1. Publications: 6.
Graft Rejection or Tolerance Affected by Serial Change of Anti-donor Lymphocyte Antibody After Liver Transplantation
ClinicalTrials.gov study NCT01444079. IPD Sharing: Not stated. Countries: 1. Publications: 1.
FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies
ClinicalTrials.gov study NCT04245722. IPD Sharing: NO. Countries: 1. Publications: 2.
Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2
ClinicalTrials.gov study NCT00003995. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19
ClinicalTrials.gov study NCT04746092. IPD Sharing: NO. Countries: 1. Publications: 2.
Diaplacental Transfer of Anti-HCMV- and Anti-VZV-immunoglobulin G (IgG) -Antibodies at Premature and Mature Newborns
ClinicalTrials.gov study NCT02689700. IPD Sharing: NO. Countries: 1. Publications: 4.
Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma
ClinicalTrials.gov study NCT05502991. IPD Sharing: NO. Countries: 1. Publications: 1.
Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Le
ClinicalTrials.gov study NCT00189345. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.